Red List

BEAMBeam Therapeutics Inc.

Healthcare · Biotechnology · mid-cap ($3.0B)
-30.7%
from rolling 252-day high of $38.26 set 2026-07-07 · 37d ago
Current
$26.51
Decline depth
-30.7%
Decline σ
2.3σ
TFC
3/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since tracking began

$BEAM has been tracked since 2026-03-01. It was down 21.3% from its 52-week high then — now down -30.7%.

That's 5.3 percentage points deeper than the day it joined. It bottomed 39.9% below that high along the way.

Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

BEAM qualifies for the Red List on decline depth.

Decline depth
-30.7%
From rolling 252-day high of $38.26, 37d ago. Past the 30% Amber threshold.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 3/5 Watch threshold.
Decline sigma
2.3σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (3.41% per day).

The structural read

What price action says about BEAM.

BEAM qualifies for the Red List on decline depth — down -30.7% from its rolling 252-day high. Past 30% with the high set inside the last four months — the recency clause that often precedes further breakdown. Depth plus recency: this is the pattern many investors call a falling knife.

Cross-confirmation: also showing 3/5 bearish time frames.

Upstream TFC read: weak alignment, current phase daily. Last bar types — daily 3 (red), weekly 1 (red), monthly 1 (green).

Earnings on file: 2026-05-07. Tiering is unaffected by earnings dates — listings reflect price structure only.

Questions about BEAM

What people ask.

Why is BEAM on Broken Stocks?

BEAM qualifies for the Red List on decline depth. It is down -30.7% from its rolling 252-day high of $38.26, set on 2026-07-07 — 37d ago.

Is BEAM a falling knife?

By the most common technical definition — a steep, recent breakdown from a fresh high — yes. BEAM is down -30.7% from its 52-week high of $38.26, set 37d ago. That combination of depth (past the 30% Amber threshold) and recency (high set inside the last 120 days) is the textbook falling-knife pattern. Whether to try to catch it is a separate question — historically most attempts to bottom-pick continue lower before reversing. Broken Stocks flags the pattern; it does not recommend buying or selling.

Is BEAM a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is BEAM trading inside its 52-week range?

At $26.51, BEAM sits 52.4% of the way from its 52-week low ($15.60) to its 52-week high ($36.44). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has BEAM been declining?

The current 30.7% decline accrued over 37d, which annualizes to roughly -302.9% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does BEAM compare to its sector?

There are 140 other Healthcare tickers on Broken Stocks: 67 Red, 34 Amber, 39 Watch, with 48 showing recovering structural signals. Median sector decline is -36.1% — BEAM's decline is shallower than the sector median.

Does BEAM's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-07) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.